Priority Date: 20.01.12 (US 201261589029P)

USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA

  • Application ID: EP13738207
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1896
Headquarters in Munich, Hamburg, Berlin
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 171 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 20.01.2012 - Priority Date (US 201261589029P)
  • 25.07.2013 - Publication A2 (WO2013110058)
  • 26.11.2014 - Publication A2 (EP2804602)

IPC Classification